Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2022

09-05-2022 | Guillain-Barré Syndrome | Editorial

Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: Real or Imagined?

Authors: Hersh Shroff, Oren K. Fix

Published in: Digestive Diseases and Sciences | Issue 9/2022

Login to get access

Excerpt

When a new vaccine is administered over a short time period to millions of individuals, any adverse event that follows can be presumed to be an effect of the vaccine [1]. It is difficult, however, to establish with certainty a causal relationship between vaccination and adverse events, with few possible exceptions such as anaphylaxis and vaccine-strain infections after live viral vaccination. For decades, a variety of vaccines have been implicated in eliciting an autoimmune response, some with credible evidence supporting causality (e.g., diphtheria toxin and Guillain-Barré syndrome (GBS), MMR vaccination and thrombocytopenic purpura) [2], and others in which extensive review has failed to demonstrate a causal link (e.g., hepatitis B vaccine and multiple sclerosis) [3]. …
Literature
1.
go back to reference Marshall E. A shadow falls on hepatitis B vaccination effort. Science. 1998;281:630–631.CrossRef Marshall E. A shadow falls on hepatitis B vaccination effort. Science. 1998;281:630–631.CrossRef
2.
go back to reference Stratton KR, Howe CJ, Johnston RB. Adverse events associated with childhood vaccines other than Pertussis and Rubella: Summary of a report from the Institute of Medicine. JAMA 1994;271:1602–1605.CrossRef Stratton KR, Howe CJ, Johnston RB. Adverse events associated with childhood vaccines other than Pertussis and Rubella: Summary of a report from the Institute of Medicine. JAMA 1994;271:1602–1605.CrossRef
3.
go back to reference Mouchet J, Salvo F, Raschi E et al. Hepatitis B vaccination and the putative risk of central demyelinating disease: a systematic review and meta-analysis. Vaccine. 2018;36:1548–1555.CrossRef Mouchet J, Salvo F, Raschi E et al. Hepatitis B vaccination and the putative risk of central demyelinating disease: a systematic review and meta-analysis. Vaccine. 2018;36:1548–1555.CrossRef
4.
go back to reference Oliver SE, Wallace M, See I et al. Use of Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the Advisory Committee on Immunization Practices—United States, December 2021. MMWR Morb Mortal Wkly Rep. 2022;71:90–95.CrossRef Oliver SE, Wallace M, See I et al. Use of Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the Advisory Committee on Immunization Practices—United States, December 2021. MMWR Morb Mortal Wkly Rep. 2022;71:90–95.CrossRef
5.
go back to reference Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of receipt of the Ad26.COV2.S vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA 2021;326:1606–13.CrossRef Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of receipt of the Ad26.COV2.S vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA 2021;326:1606–13.CrossRef
6.
go back to reference Lee EJ, Cines DB, Gernsheimer T et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96:534–537.CrossRef Lee EJ, Cines DB, Gernsheimer T et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96:534–537.CrossRef
9.
go back to reference Lodato F, Larocca A, D’Errico A et al. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury. J Hepatol. 2021;75:1254–1256.CrossRef Lodato F, Larocca A, D’Errico A et al. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: coincidence, autoimmunity or drug-related liver injury. J Hepatol. 2021;75:1254–1256.CrossRef
10.
go back to reference Hennes EM, Zeniya M, Czaja AJ et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.CrossRef Hennes EM, Zeniya M, Czaja AJ et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.CrossRef
11.
go back to reference Shroff H, Satapathy SK, Crawford JM et al. Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol. 2022;76:211–214.CrossRef Shroff H, Satapathy SK, Crawford JM et al. Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol. 2022;76:211–214.CrossRef
12.
go back to reference Csepregi A, Treiber G, Rockën C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix. World J Gastroenterol. 2005;11:4114–4116.CrossRef Csepregi A, Treiber G, Rockën C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix. World J Gastroenterol. 2005;11:4114–4116.CrossRef
13.
go back to reference Cao Z, Gui H, Sheng Z et al. Letter to the editor: exacerbation of autoimmune hepatitis after COVID-19 vaccination. Hepatology. 2021;75:757–759.CrossRef Cao Z, Gui H, Sheng Z et al. Letter to the editor: exacerbation of autoimmune hepatitis after COVID-19 vaccination. Hepatology. 2021;75:757–759.CrossRef
14.
go back to reference Bjornnson E, Talwalkar J, Treeprasertsuk S et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:2040–2048.CrossRef Bjornnson E, Talwalkar J, Treeprasertsuk S et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:2040–2048.CrossRef
15.
go back to reference Cjaza A. Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis. Dig Dis Sci. 2017;62:2277–2292.CrossRef Cjaza A. Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis. Dig Dis Sci. 2017;62:2277–2292.CrossRef
Metadata
Title
Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: Real or Imagined?
Authors
Hersh Shroff
Oren K. Fix
Publication date
09-05-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07509-5

Other articles of this Issue 9/2022

Digestive Diseases and Sciences 9/2022 Go to the issue

PROFILES AND PERSPECTIVES

DDS Profile: Daniel Hollander, MD